Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance January 3, 2020 Kelsey Cahill Merkel Cell Carcinoma, Publication
Imaging of Merkel Cell Carcinoma: What Imaging Experts Should Know January 3, 2020 Kelsey Cahill Merkel Cell Carcinoma, Publication
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma January 3, 2020 Kelsey Cahill Merkel Cell Carcinoma, Publication
Less Toxic, More Effective Treatment—A Win-Win for Patients With Merkel Cell Carcinoma January 3, 2020 Kelsey Cahill Merkel Cell Carcinoma, Publication
Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain January 3, 2020 Kelsey Cahill Merkel Cell Carcinoma, Publication
Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA July 2, 2019 Kelsey Cahill Merkel Cell Carcinoma, Publication
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. June 17, 2019 Kelsey Cahill Merkel Cell Carcinoma, Publication
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab. June 17, 2019 Kelsey Cahill Merkel Cell Carcinoma, Publication
Effect of Patient Immune Status on the Efficacy of Radiation Therapy and Recurrence-Free Survival Among 805 Patients With Merkel Cell Carcinoma. June 17, 2019 Kelsey Cahill Merkel Cell Carcinoma, Publication
The biology and treatment of Merkel cell carcinoma: current understanding and research priorities. June 17, 2019 Kelsey Cahill Merkel Cell Carcinoma, Publication
Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma: Impact of Immunosuppression Type on Cancer-specific and Overall Survival. June 17, 2019 Kelsey Cahill Merkel Cell Carcinoma, Publication
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy. June 17, 2019 Kelsey Cahill Merkel Cell Carcinoma, Publication
